HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 96 filers reported holding HARVARD BIOSCIENCE INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $695,822 | +28.5% | 161,819 | +64.0% | 0.00% | +33.3% |
| Q2 2023 | $541,561 | +41.8% | 98,645 | +81.8% | 0.00% | +50.0% |
| Q4 2021 | $382,000 | -21.1% | 54,252 | -21.7% | 0.00% | -33.3% |
| Q3 2021 | $484,000 | -5.7% | 69,312 | +12.6% | 0.00% | 0.0% |
| Q2 2021 | $513,000 | +50.0% | 61,563 | -1.8% | 0.00% | +50.0% |
| Q1 2021 | $342,000 | -0.3% | 62,700 | -21.7% | 0.00% | 0.0% |
| Q4 2020 | $343,000 | +15.9% | 80,049 | -18.5% | 0.00% | 0.0% |
| Q3 2020 | $296,000 | +96.0% | 98,223 | +101.3% | 0.00% | +100.0% |
| Q2 2020 | $151,000 | +49.5% | 48,800 | +6.6% | 0.00% | 0.0% |
| Q1 2020 | $101,000 | -19.8% | 45,775 | +11.1% | 0.00% | 0.0% |
| Q4 2019 | $126,000 | -1.6% | 41,200 | -1.2% | 0.00% | 0.0% |
| Q3 2019 | $128,000 | +75.3% | 41,700 | +225.8% | 0.00% | 0.0% |
| Q4 2014 | $73,000 | +49.0% | 12,800 | +5.8% | 0.00% | – |
| Q3 2014 | $49,000 | – | 12,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AMH Equity Ltd | 2,053,907 | $8,626,409 | 9.88% |
| B. Riley Asset Management, LLC | 3,408,796 | $14,316,943 | 5.93% |
| Meros Investment Management, LP | 1,124,206 | $4,721,665 | 2.69% |
| Harvey Partners, LLC | 2,712,700 | $11,393,340 | 1.41% |
| Archon Capital Management LLC | 1,361,769 | $5,719,430 | 1.28% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 2,947,329 | $12,378,782 | 0.80% |
| BARD ASSOCIATES INC | 291,297 | $1,223,448 | 0.50% |
| Portolan Capital Management | 1,043,546 | $4,382,893 | 0.42% |
| HEARTLAND ADVISORS INC | 1,200,000 | $5,040,000 | 0.31% |
| EAM Investors, LLC | 345,546 | $1,451,293 | 0.28% |